Phase 1-2 of Temozolomide and Hypofractionated Radiotherapy in Tx of Supratentorial Glioblastoma Multiform
Condition(s):Glioblastoma; Cancer of Brain and Nervous System; Glioblastoma MultiformeLast Updated:August 6, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Glioblastoma; Cancer of Brain and Nervous System; Glioblastoma MultiformeLast Updated:August 6, 2021Completed
Condition(s):Glioblastoma; Glioblastoma Multiforme; Glioma, Malignant; GBM; Brain Cancer; Glioblastoma, IDH-wildtype; Glioblastoma Multiforme, AdultLast Updated:May 30, 2023Recruiting
Condition(s):Gastroenteropancreatic Neuroendocrine TumorsLast Updated:May 6, 2019Completed
Condition(s):Glioblastoma MultiformeLast Updated:May 20, 2009Withdrawn
Condition(s):Lung Cancer and Breast Cancer Patients With Brain MetastasesLast Updated:May 8, 2014Unknown status
Condition(s):Glioblastoma Multiforme; GliosarcomaLast Updated:March 19, 2014Completed
Condition(s):Initial Radiological Diagnosis Eligible for Tumor Resection; Initial Radiological Diagnosis Compatible With Newly Diagnosed Glioblastoma (IDH Wild-type); Eligible for the Standard of Care Including Concurrent Temoradiation and Adjuvant TemozolomideLast Updated:March 29, 2022Unknown status
Condition(s):Advanced Malignant Solid Neoplasm; Advanced Microsatellite Stable Colorectal Carcinoma; Hematopoietic and Lymphatic System Neoplasm; Metastatic Malignant Solid Neoplasm; Metastatic Microsatellite Stable Colorectal Carcinoma; Stage III Colorectal Cancer AJCC v8; Stage IV Colorectal Cancer AJCC v8Last Updated:March 6, 2024Recruiting
Condition(s):Refractory or Recurrent Neuroblastoma in ChildrenLast Updated:April 13, 2021Unknown status
Condition(s):GlioblastomaLast Updated:June 14, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.